Stock Price & Analysis

Based on the recent price action and technical indicators, NMR stock shows a bullish trend with the price currently trading at $6.76, maintaining above key moving averages. The RSI at 62.81 indicates moderate bullish momentum without being overbought.

The stock has demonstrated positive momentum with increasing institutional interest and improving fundamentals. Recent earnings showed strong performance with investment banking income up 14% and overseas pretax profit nearly quadrupling to JPY 51.8 billion.

Considering the technical setup and fundamental improvements, NMR appears to be a buy at current levels, with potential upside targeting the Fibonacci R1 level at $6.94.

Price Analysis and Forecast

Based on the technical analysis and market data, here's the price prediction for NMR stock in 2025:

NMR is expected to reach $7.10 by end of 2025, representing a potential upside of 5.2% from current levels. This target is supported by the following factors:

1. Strong technical support at $6.50 level with Fibonacci support levels showing S1 at $6.41
2. Positive RSI-14 reading at 62.81 indicating moderate bullish momentum without being overbought
3. MACD showing positive divergence with MACD line (0.22) above signal line (0.21)

Technical Indicators Support

The stock is currently trading above all major moving averages:

• Above 20-day SMA ($6.50)
• Above 60-day SMA ($6.11)
• Above 200-day SMA ($5.80)

This indicates a strong upward trend structure is in place.

Risk Factors

The main downside risk would be a break below the $6.41 Fibonacci S1 support level, which could trigger a decline toward $6.25 (S2 level). However, multiple support levels and positive technical indicators suggest limited downside risk.

The S1 support level for NMR Stock is $6.49 ,The R1 resistant level for NMR Stock is $6.85.

As of the end of day on 2025-02-21, the price of NMR Stock was $6.48.

The market cap of NMR is $20.5B.

Based on the provided data and recent market analysis, here's a concise evaluation of NMR's valuation:

Nomura Holdings (NMR) appears fairly valued at current levels based on several key metrics. The P/E ratio has increased from 10.48 in FY2022 to 17.29 in FY2023, indicating higher market expectations. Net income declined significantly from $1.27B to $685.7M in FY2023, showing deteriorating profitability.

The stock's technical indicators show moderate strength with RSI-14 at 62.81, suggesting neither overbought nor oversold conditions. The stock is trading above its major moving averages (SMA 200 at 5.80), indicating positive momentum.

The company's ROE dropped from 5.27% to 2.88% year-over-year, while net margin decreased from 9.19% to 3.69%, suggesting declining operational efficiency. However, recent earnings showed improvement with investment banking income increasing by 14% and overseas pretax profit nearly quadrupling.

The current price of $6.76 sits between Fibonacci support at $6.41 and resistance at $6.94, suggesting a balanced risk-reward setup.

Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.

Based on the provided data and market analysis, here is the price prediction for NMR stock by 2030:

NMR stock is projected to reach $12.50 by 2030, representing an 85% upside from current levels around $6.76, driven by the company's strong technical indicators and positive momentum in the AI and data science sector. The stock shows a bullish RSI of 62.81 and favorable MACD crossover pattern, suggesting sustained upward momentum. The Fibonacci projections indicate strong support at $6.41 with resistance at $7.10, providing a solid foundation for long-term growth.

NMR has a total of 26853 employees.